Tofacitinib Tablet
brand name - Xeljanz, Tofatop
Tofacitinib is a JAK inhibitor. It blocks Janus kinase enzymes, which are involved in the signaling pathways that drive inflammation. Main uses: moderate to severe rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and polyarticular juvenile idiopathic arthritis in kids — usually when other treatments haven't worked. Adult dose is typically 5 milligrams twice daily. For ulcerative colitis, it's 10 milligrams twice daily for the first 8 weeks, then reduced. Extended-release tablets come in 11 milligrams or 22 milligrams once daily.
Comments
Post a Comment